XML 41 R7.htm IDEA: XBRL DOCUMENT v3.20.1
CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
Common Shares [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
Convertible Preferred Stock [Member]
Total
Balance at Dec. 31, 2018 $ 0 $ 179,503,000 $ (45,000) $ (175,640,000) $ 0 $ 3,818,000
Balance (in shares) at Dec. 31, 2018 769,890       0  
Release of restricted common stock $ 0 (65,000) 0 0 $ 0 (65,000)
Release of restricted common stock (in shares) 6,193,000       0  
Issuance of warrants for common stock $ 0 0 0 0 $ 0 0
Issuance of warrants for common stock (in shares) 0       0  
Currency translation adjustment $ 0 0 (11,000) 0 $ 0 (11,000)
Net loss 0 0 0 (2,565,000) 0 (2,565,000)
Balance at Mar. 31, 2019 $ 0 179,438,000 (56,000) (178,205,000) $ 0 1,177,000
Balance (in shares) at Mar. 31, 2019 776,083       0  
Balance at Dec. 31, 2019 $ 0 188,320,000 (48,000) (187,678,000) $ 517,000 594,000 [1]
Balance (in shares) at Dec. 31, 2019 1,245,238       250,000  
Issuance of common stock and warrants, net of offering costs $ 0 725,000 0 0 $ 0 725,000
Issuance of common stock, net of issuance costs (in shares) 91,062          
Issuance of common stock in connection with notes payable $ 0 4,000 0 0 $ 0 4,000
Issuance of common stock in connection with notes payable (in shares) 500       0  
Issuance of warrants in connection with convertible notes payable $ 0 630,000 0 0 $ 0 630,000
Convertible preferred stock dividend 0 (20,000) 0 0 20,000 (20,000)
Stock-based compensation expense $ 0 75,000 0 0 $ 0 75,000
Stock compensation expense (in shares) 2,000       0  
Restricted awards cancelled $ 0 0 0 0 $ 0 0
Restricted awards cancelled (in shares) (550,000)       0  
Release of restricted common stock $ 0 0 0 0 $ 0 0
Release of restricted common stock (in shares) 353       0  
Issuance of warrants for common stock, in connection with convertible preferred stock offering (in shares)         0  
Net loss $ 0 0 0 (2,680,000) $ 0 (2,680,000)
Balance at Mar. 31, 2020 $ 0 $ 189,734,000 $ (48,000) $ (190,358,000) $ 537,000 $ (672,000)
Balance (in shares) at Mar. 31, 2020 1,338,603       250,000  
[1] The condensed consolidated balance sheet as of December 31, 2019 was derived from the audited consolidated balance sheet as of that date.